dc.creator | Vavougios G.D., Stavrou V., Gourgoulianis K.I. | en |
dc.date.accessioned | 2023-01-31T10:30:41Z | |
dc.date.available | 2023-01-31T10:30:41Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1001/jamapsychiatry.2022.1773 | |
dc.identifier.issn | 2168622X | |
dc.identifier.uri | http://hdl.handle.net/11615/80538 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | JAMA Psychiatry | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134943488&doi=10.1001%2fjamapsychiatry.2022.1773&partnerID=40&md5=06fc4ba0b85236c53bf85c3eb540938a | |
dc.subject | cerebrovascular disease | en |
dc.subject | cognitive defect | en |
dc.subject | human | en |
dc.subject | psychology | en |
dc.subject | sleep disordered breathing | en |
dc.subject | Cerebrovascular Disorders | en |
dc.subject | Cognitive Dysfunction | en |
dc.subject | COVID-19 | en |
dc.subject | Humans | en |
dc.subject | Sleep Apnea Syndromes | en |
dc.subject | American Medical Association | en |
dc.title | Cerebrovascular Disease and Sleep-Disordered Breathing Need to Be Accounted for in Cognitive Impairment Following COVID-19 | en |
dc.type | other | en |